Forty-six patients with acute tinea pedis were treated with either 1% tolnaftate aerosol spray powder or 2% miconazole nitrate aerosol spray powder, not previously available. Products were coded, and the study was conducted in a double-blind manner. At the end of 28 days of therapy, 68% of the miconazole-treated group achieved therapeutic cure, versus 50% in the tolnaftate-treated group. Symptomatic relief and mycological clearing based on potassium hydroxide examination took place in less time for the patients treated with miconazole nitrate. The aerosol spray powder form is an effective alternative vehicle to both cream and solution.
Get full access to this article
View all access options for this article.
References
1.
BrugmansJ Pvan CutsemJ MThienpontD C (1970) Treatment of long term tinea pedis with miconazole; double-blind clinical evaluation. Archives of Dermatology102, 428.
2.
ClaytonY M (1979) Dermatophyte infections. Postgraduate Medical Journal55, 605.
3.
DuncanW C (1975) Tinea pedis; treatment with topical miconazole. Cutis16, 647.
4.
FultonJ E (1975) Miconazole therapy for endemic fungal diseases. Archives of Dermatology111, 596.
5.
ShellowW V R (1979) Current antifungal therapy. Western Journal of Medicine130, 155.
6.
SmithE B (1976) New topical agents for dermatophytosis. Cutis17, 54.
7.
TaplinDZaiasNRebellGBlankH (1969) Isolation and recognition of dermatophytes on a new medium (DTM). Archives of Dermatology99, 203.
8.
van CutsemJ MThienpontD C (1972) Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy17, 392.
